Wear it pink on 24 October Wear pink. Raise money. Help make life-changing breast cancer research and support happen.
Home About us Media Breast Cancer Now media statements 215 results We respond to the Clinical Radiology UK Workforce Census 2020 Report from The Royal College of Radiologists 28 Apr 2021 2 min read We welcome the approval of trastuzumab deruxtecan for use on the Cancer Drugs Fund 20 Apr 2021 4 min read We respond to NHS England breast cancer waiting times: February 2021 15 Apr 2021 2 min read We welcome introduction of new treatment method for HER2 positive breast cancer by NHS England 04 Apr 2021 1 min read We respond to new study into early-stage breast cancer treatment in UK during initial months of COVID-19 pandemic 29 Mar 2021 2 min read We respond to a new study about lifestyle and breast cancer risk 25 Mar 2021 1 min read We respond to NHS England breast cancer waiting times: January 2021 15 Mar 2021 3 min read We respond to a study from King's College London into the effectiveness of the Pfizer COVID-19 vaccine for people with cancer 11 Mar 2021 1 min read We welcome NICE approval of ribociclib with fulvestrant for use on the NHS 26 Feb 2021 3 min read We respond to draft NICE decision not to recommend abemaciclib with fulvestrant for routine use on the NHS 12 Feb 2021 3 min read We respond to breast cancer becoming the most common cancer globally 05 Feb 2021 1 min read We Respond to Breast Cancer Screening Performance Data for England 2019/20 28 Jan 2021 3 min read Previous 1 ... 17 18 Next
We respond to the Clinical Radiology UK Workforce Census 2020 Report from The Royal College of Radiologists 28 Apr 2021 2 min read
We welcome the approval of trastuzumab deruxtecan for use on the Cancer Drugs Fund 20 Apr 2021 4 min read
We welcome introduction of new treatment method for HER2 positive breast cancer by NHS England 04 Apr 2021 1 min read
We respond to new study into early-stage breast cancer treatment in UK during initial months of COVID-19 pandemic 29 Mar 2021 2 min read
We respond to a study from King's College London into the effectiveness of the Pfizer COVID-19 vaccine for people with cancer 11 Mar 2021 1 min read
We respond to draft NICE decision not to recommend abemaciclib with fulvestrant for routine use on the NHS 12 Feb 2021 3 min read
